Is Jyothy Labs overvalued or undervalued?

As of 14 October 2025, Jyothy Labs has moved from a very attractive to an attractive valuation grade. The company appears to be fairly valued based on its current metrics, with a PE ratio of 30.59, an EV to EBITDA of 21.79, and a ROCE of 29.33%. In comparison to its peers, Jyothy Labs' PE ratio is significantly lower than Hindustan Unilever's 55.24 and Nestle India's 75.31, both of which are classified as very expensive. Despite the recent decline in stock performance, with a year-to-date return of -21.72% compared to the Sensex's 4.98%, Jyothy Labs maintains a solid position within the FMCG sector. The company's PEG ratio of 0.00 indicates potential for growth, although it is essential to monitor market conditions and competitive pressures moving forward. Overall, Jyothy Labs is fairly valued in the current market context.